Joshi Tanmaya, Voo Zhi Xiang, Graham Bim, Spiccia Leone, Martin Lisandra L
School of Chemistry, Monash University, Clayton, Victoria 3800, Australia.
Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.
Biochim Biophys Acta. 2015 Feb;1848(2):385-91. doi: 10.1016/j.bbamem.2014.10.019. Epub 2014 Oct 23.
The rapid increase in multi-drug resistant bacteria has resulted in previously discontinued treatments being revisited. Aminoglycosides are effective "old" antibacterial agents that fall within this category. Despite extensive usage and understanding of their intracellular targets, there is limited mechanistic knowledge regarding how aminoglycosides penetrate bacterial membranes. Thus, the activity of two well-known aminoglycosides, kanamycin A and neomycin B, towards a bacterial mimetic membrane (DMPC:DMPG (4:1)) was examined using a Quartz Crystal Microbalance with Dissipation monitoring (QCM-D). The macroscopic effect of increasing the aminoglycoside concentration showed that kanamycin A exerts a threshold response, switching from binding to the membrane to disruption of the surface. Neomycin B, however, disrupted the membrane at all concentrations examined. At concentrations above the threshold value observed for kanamycin A, both aminoglycosides revealed similar mechanistic details. That is, they both inserted into the bacterial mimetic lipid bilayer, prior to disruption via loss of materials, presumably aminoglycoside-membrane composites. Depth profile analysis of this membrane interaction was achieved using the overtones of the quartz crystal sensor. The measured data is consistent with a two-stage process in which insertion of the aminoglycoside precedes the 'detergent-like' removal of membranes from the sensor. The results of this study contribute to the insight required for aminoglycosides to be reconsidered as active antimicrobial agents/co-agents by providing details of activity at the bacterial membrane. Kanamycin and neomycin still offer potential as antimicrobial therapeutics for the future and the QCM-D method illustrates great promise for screening new antibacterial or antiviral drug candidates.
多重耐药菌的迅速增加导致人们重新审视以前已停止使用的治疗方法。氨基糖苷类药物就是属于这一类别的有效的“老”抗菌剂。尽管对其细胞内靶点有广泛的使用和了解,但关于氨基糖苷类药物如何穿透细菌膜的机制知识却很有限。因此,使用带耗散监测的石英晶体微天平(QCM-D)研究了两种著名的氨基糖苷类药物卡那霉素A和新霉素B对模拟细菌膜(二肉豆蔻酰磷脂酰胆碱:二肉豆蔻酰磷脂酰甘油(4:1))的活性。增加氨基糖苷类药物浓度的宏观效应表明,卡那霉素A表现出阈值响应,从与膜结合转变为破坏表面。然而,新霉素B在所有检测浓度下都会破坏膜。在高于卡那霉素A观察到的阈值浓度时,两种氨基糖苷类药物都显示出相似的机制细节。也就是说,它们都先插入模拟细菌的脂质双层,然后通过物质损失(可能是氨基糖苷类-膜复合物)导致膜破坏。利用石英晶体传感器的泛音对这种膜相互作用进行了深度剖析分析。测量数据与一个两阶段过程一致,其中氨基糖苷类药物的插入先于从传感器上“类似去污剂”地去除膜。这项研究的结果通过提供在细菌膜上的活性细节,有助于深入了解将氨基糖苷类药物重新视为活性抗菌剂/辅助剂所需的信息。卡那霉素和新霉素在未来仍具有作为抗菌治疗药物的潜力,并且QCM-D方法在筛选新的抗菌或抗病毒候选药物方面显示出巨大的前景。